Table 1.
Group | N | CD29 | CD44 | CD34 | CD45 |
---|---|---|---|---|---|
hBMSC P3 | 5 | 98.10 ± 1.10 | 94.99 ± 1.00 | 0.32 ± 0.12 | 1.78 ± 0.44 |
hPPE-hBMSC | 5 | 99.08 ± 0.55 | 95.07 ± 2.35 | 0.43 ± 0.40 | 1.48 ± 0.45 |
pBABE-hBMSC | 5 | 98.99 ± 0.59 | 93.37 ± 2.36 | 0.57 ± 0.35 | 1.82 ± 0.49 |
F value | — | 2.368 | 1.141 | 0.815 | 0.796 |
P value | — | 0.136 | 0.352 | 0.466 | 0.474 |
Cultured hBMSC, pBABE-hBMSC, and hPPE-hBMSC at passage 3 were analyzed for CD 29, 34, 44, and 45 expression using FACS. The lack of CD 34 and 45 expression and presence of CD 29 and 44 expressions indicate a mesenchymal stem cell lineage after transfection. hPPE, human proenkephalin; hBMSC, human bone marrow stem cell; pBABE-hBMSC, the pBABE-hBMSC group; hPPE-hBMSCs, the hPPE-hBMSC group.